Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Action On Antidepressants Questioned; Congress Widens Investigation

Executive Summary

House and Senate Committees are requesting documentation from FDA officials on what and when they knew about a possible link between antidepressants and suicidal behavior

You may also be interested in...



FDA Employee Misconduct Charges To Be Investigated By OIG Instead Of Itself

A "stronger appearance of impartiality, integrity" will result from an HHS Office of Inspector General decision to take back investigative authority over allegations of employee misconduct at FDA, a GOP aide to the House Energy & Commerce Committee told "The Pink Sheet.

FDA Employee Misconduct Charges To Be Investigated By OIG Instead Of Itself

A "stronger appearance of impartiality, integrity" will result from an HHS Office of Inspector General decision to take back investigative authority over allegations of employee misconduct at FDA, a GOP aide to the House Energy & Commerce Committee told "The Pink Sheet.

Antidepressant Suicidality Needs Interim Risk Management, FDAer Maintains

FDA should establish an interim risk management plan to discourage pediatric antidepressant use, FDA epidemiologist Andrew Mosholder, MD, maintained in an Aug. 16 memo

Related Content

UsernamePublicRestriction

Register

ID004339

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel